sorbitol has been researched along with Lymphoma, Non-Hodgkin in 1 studies
D-glucitol : The D-enantiomer of glucitol (also known as D-sorbitol).
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Voest, EE | 1 |
| Neijt, JP | 1 |
| Keunen, JE | 1 |
| Dekker, AW | 1 |
| van Asbeck, BS | 1 |
| Nortier, JW | 1 |
| Ros, FE | 1 |
| Marx, JJ | 1 |
1 trial available for sorbitol and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Citrates; Citric Acid; Deferoxamine; Do | 1993 |